In 6 clinical trials conducted between 1992 and 2000, PROCOMVAX was administered to 2528 infants, approximately 2 months of age, who had not previously received any Hib vaccine.
1992. kuni 2000. aastal läbiviidud kuues kliinilises uuringus manustati PROCOMVAX’ i 2528- le umbes 2 kuu vanusele lapsele, kes ei olnud varem saanud Haemophilus influenzae tüüp b (Hib) vaktsiini.